Deontics develops first executable Covid 19 clinical pathway

April 7, 2020

In collaboration with the Royal Liverpool Hospital, Deontics has developed the first executable Covid 19 treatment pathway. This provides evidence-based, personalised, treatment recommendations at the point of care to physicians and nurses treating Covid 19 patients. It is particularly helpful for non-respiratory specialist physicians who are treating such patients, and is a mechanism of delegating expertise and effectively increasing clinical capacity. It also automatically collects epidemiological data, freeing front line clinicians from this task.The executable Covid 19 treatment pathway was developed very quickly and shows the capability of the Deontics platform to encode clinical logic into a standardised digital logic model to make it executable, editable and deployable.

The Covid 19 treatment pathway, with modifications for local practice, can potentially be used in health systems around the world.